Compare VanEck Rare Earth/Strategic Metals (REMX) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Rare Earth/Strategic Metals vs DENTSPLY SIRONA Inc — how do they compare? VanEck Rare Earth/Strategic Metals trades at $61.8 (market cap $1.75B), while DENTSPLY SIRONA Inc trades at $8.78 (market cap $1.73B). The key difference: VanEck Rare Earth/Strategic Metals and DENTSPLY SIRONA Inc are close in size by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while VanEck Rare Earth/Strategic Metals pays none. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Rare Earth/Strategic Metals for 50 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| REMX | XRAY | |
|---|---|---|
Market Cap | $1.75B | $1.73B |
Volume | 930,523 | 6,198,582 |
Sector | Sector/Thematic | Health |
52-Week High | $109.53 | $14.68 |
52-Week Low | $60.58 | $8.52 |
Typical Hold Time | 50 Days | 72 Days |
Enterprise Value | — | $3.80B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
REMX (VanEck Rare Earth and Strategic Metals ETF) is trading at $61.88, down 2.99% with a bearish technical signal. The ETF faces selling pressure across moving averages and oscillators, though RSI readings below 23 suggest potential oversold conditions. Recent news highlights increased institutional interest from Bank of America while the rare earth sector navigates geopolitical tensions and U.S. supply chain developments.
The ETF's high volatility (~50% annualized) and China-heavy exposure present significant risks, though strategic importance of rare earth metals for defense and technology offers long-term thematic appeal. Current technical weakness contrasts with fundamental tailwinds from U.S. supply chain initiatives, creating a contested investment case requiring careful risk assessment.
DENTSPLY SIRONA (XRAY) trades at $8.54, near a 52-week low, with a bearish technical signal from moving averages. The company reported a Q2 2026 earnings beat but faces declining revenues and negative net income margins. Recent news highlights institutional stake increases and ongoing turnaround efforts amid sales weakness in dental segments.
The outlook remains challenging due to persistent profitability issues and high debt, though analyst consensus suggests upside to a $13.40 price target. Key risks include margin pressure and competitive threats, while potential catalysts include successful restructuring and digital dentistry growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Rare Earth/Strategic Metals
REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.
Read more on REMX →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
